Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$659,686
+$561,271 QoQ
Shares Held
550
+414.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#3,512
of 4,605 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E Fund Management (Hong Kong) Co., Ltd. holds $3,941,164 across 15 Drug Manufacturers - General names. LLY ranks #3 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
3,127 | $1,132,349 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
7,092 | $896,003 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
550 | $659,686 | |
| 4 | JNJ |
Johnson & Johnson
|
2,260 | $573,972 | |
| 5 | ABBV |
AbbVie Inc.
|
1,288 | $324,112 | |
| 6 | MRK |
Merck & Co., Inc.
|
939 | $120,661 | |
| 7 | PFE |
Pfizer Inc
|
2,154 | $51,868 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
507 | $29,213 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $659,686 | 550 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $98,415 | 107 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $33,315 | 31 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,341 | 7 | Shares | Sole | 2025-10-23 | |
| 2024-12-31 | $104,992 | 136 | Shares | Sole | 2025-01-22 | |
| 2024-03-31 | $94,133 | 121 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||